|
"hsu ti"的相關文件
顯示項目 1-25 / 54 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-07-14 |
Contribution of prostaglandin E2-induced neuronal excitation to drug resistance in glioblastoma countered by a novel blood-brain barrier crossing celecoxib derivative
|
Shen, CJ;Chen, HC;Lin, CL;Thakur, A;Onuku, R;Chen, IC;Li, HY;Chang, KY;Chuang, JY;Yang, WB;Lin, HY;Shen, YR;Liou, JP;Chang, WC;Hsu, TI |
| 國家衛生研究院 |
2025-01 |
Potential role of solid lipid curcumin particle (SLCP) as estrogen replacement therapy in mitigating TDP-43-related neuropathy in the mouse model of ALS disease
|
Majumder, P;Hsu, TI;Hu, CJ;Huang, JK;Lee, YC;Hsieh, YC;Ahsan, A;Huang, CC |
| 國家衛生研究院 |
2024-10 |
Exploring neuron-specific steroid synthesis and DHEAS therapy in Alzheimer's disease
|
Lin, HY;Feng, YH;Kao, TJ;Chen, HC;Chen, GY;Ko, CY;Hsu, TI |
| 國家衛生研究院 |
2024-04-17 |
Overcoming the blood-brain tumor barrier with docetaxel-loaded mesoporous silica nanoparticles for treatment of temozolomide-resistant glioblastoma
|
Hsu, TI;Chen, YP;Zhang, RL;Chen, ZA;Wu, CH;Chang, WC;Mou, CY;Chan, HWH;Wu, SH |
| 國家衛生研究院 |
2024-04-01 |
Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress
|
Sharma, R;Chiang, YH;Chen, HC;Lin, HY;Yang, WB;Nepali, K;Lai, MJ;Chen, KY;Liou, JP;Hsu, TI |
| 國家衛生研究院 |
2024-03 |
Mitochondrial mechanisms in temozolomide resistance: Un-raveling the complex interplay and therapeutic strategies in glioblastoma
|
Li, HY;Feng, YH;Lin, CL;Hsu, TI |
| 國家衛生研究院 |
2024-01-29 |
First-in-class dual EZH2-HSP90 inhibitor eliciting striking antiglioblastoma activity in vitro and in vivo
|
Sharma, S;Wang, SA;Yang, WB;Lin, HY;Lai, MJ;Chen, HC;Kao, TY;Hsu, FL;Nepali, K;Hsu, TI;Liou, JP |
| 國家衛生研究院 |
2024-01-18 |
Neurocutaneous melanosis with meningeal melanocytosis: A rare case of intracranial hypertension and cutaneous manifestations
|
Chen, HC;Hsu, TI;Chao, TY;Yang, ST |
| 國家衛生研究院 |
2023-11-07 |
Correlation of insulin-like growth factor 1 with cognitive functions in mild traumatic brain injury patients
|
Ou, JC;Feng, YH;Chen, KY;Chiang, YH;Hsu, TI;Wu, CC |
| 國家衛生研究院 |
2023-08-03 |
Dysregulated lipid metabolism in TMZ-resistant glioblastoma: Pathways, proteins, metabolites and therapeutic opportunities
|
Kao, TJ;Lin, CL;Yang, WB;Li, HY;Hsu, TI |
| 國家衛生研究院 |
2023-08 |
Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma
|
Tseng, HJ;Banerjee, S;Qian, B;Lai, MJ;Wu, TY;Hsu, TI;Lin, TE;Hsu, KC;Chuang, KH;Liou, JP;Shih, JC |
| 國家衛生研究院 |
2023-07-22 |
The complex role of eicosanoids in the brain: Implications for brain tumor development and therapeutic opportunities
|
Chen, HC;Chang, WC;Chuang, JY;Chang, KY;Liou, JP;Hsu, TI |
| 國家衛生研究院 |
2023-07-14 |
Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma
|
Hsu, TI |
| 國家衛生研究院 |
2022-08-18 |
CCAAT/enhancer-binding protein delta regulates glioblastoma survival through catalase-mediated hydrogen peroxide clearance
|
Lin, HY;Lim, SW;Hsu, TI;Yang, WB;Huang, CC;Tsai, YT;Chang, WC;Ko, CY |
| 國家衛生研究院 |
2022-05 |
Allopregnanolone suppresses glioblastoma survival through decreasing DPYSL3 and S100A11 expression
|
Feng, YH;Lim, SW;Lin, HY;Wang, SA;Hsu, SP;Kao, TJ;Ko, CY;Hsu, TI |
| 國家衛生研究院 |
2022-03-25 |
Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation
|
Tsai, YT;Lo, WL;Chen, PY;Ko, CY;Chuang, JY;Kao, TJ;Yang, WB;Chang, KY;Hung, CY;Kikkawa, U;Chang, WC;Hsu, TI |
| 國家衛生研究院 |
2022-03-10 |
Regorafenib reverses temozolomide-induced CXCL12/CXCR4 signaling and triggers apoptosis mechanism in glioblastoma
|
Chiang, IT;Liu, YC;Liu, HS;Ali, AAA;Chou, SY;Hsu, TI;Hsu, FT |
| 國家衛生研究院 |
2022-02-02 |
HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells
|
Wu, AC;Yang, WB;Chang, KY;Lee, JS;Liou, JP;Su, RY;Cheng, SM;Hwang, DY;Kikkawa, U;Hsu, TI;Wang, CY;Chang, WC;Chen, PY;Chuang, JY |
| 國家衛生研究院 |
2021-12-20 |
L-selectin activation regulates Rho GTPase activity via Ca(+2) influx in Sertoli cell line, ASC-17D cells[Erratum:Biochemical and Biophysical Research Communications. 2020 May;525(4):1011-1017.]
|
Limanjaya, I;Hsu, TI;Chuang, JY;Kao, TJ |
| 國家衛生研究院 |
2021-09-28 |
Histone deacetylase 6 acts upstream of DNA damage response activation to support the survival of glioblastoma cells
|
Yang, WB;Wu, AC;Hsu, TI;Liou, JP;Lo, WL;Chang, KY;Chen, PY;Kikkawa, U;Yang, ST;Kao, TJ;Chen, RM;Chang, WC;Ko, CY;Chuang, JY |
| 國家衛生研究院 |
2021-08-20 |
17Beta-estradiol induces temozolomide resistance through NRF2-mediated redox homeostasis in glioblastoma
|
Lin, HY;Liao, KH;Ko, CY;Chen, GY;Hsu, SP;Hung, CY;Hsu, TI |
| 國家衛生研究院 |
2021-08-10 |
Vav2 is required for Netrin-1 receptor-class-specific spinal motor axon guidance
|
Tsou, YS;Wang, CY;Chang, MY;Hsu, TI;Wu, MT;Wu, YH;Tsai, WL;Chuang, JY;Kao, TJ |
| 國家衛生研究院 |
2021-05-31 |
NBM-BMX, an HDAC8 inhibitor, overcomes temozolomide resistance in glioblastoma multiforme by downregulating the beta-Cateninic-Myc/SOX2 pathway and upregulating p53-mediated MGMT inhibition
|
Tsai, CY;Ko, HJ;Chiou, SJ;Lai, YL;Hou, CC;Javaria, T;Huang, ZY;Cheng, TS;Hsu, TI;Chuang, JY;Kwan, AL;Chuang, TH;Huang, CYF;Loh, JK;Hong, YR |
| 國家衛生研究院 |
2021-03-16 |
Paxillin is required for proper spinal motor axon growth into the limb
|
Tsai, WL;Chang, CJ;Wang, CY;Hsu, TI;Chang, MY;Wu, YH;Chang, PS;Lin, KL;Chuang, JY;Kania, A;Kao, TJ |
| 國家衛生研究院 |
2020-04-24 |
Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma
|
Yang, WB;Hsu, CC;Hsu, TI;Liou, JP;Chang, KY;Chen, PY;Liu, JJ;Yang, ST;Wang, JY;Yeh, SH;Chen, RM;Chang, WC;Chuang, JY |
顯示項目 1-25 / 54 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
|
